by Christina Crowe
After five and a half years serving as Director of the Division of Molecular & Cellular Pathology, Ralph Sanderson, Ph.D., is stepping down in his role. Sanderson plans to retire from UAB on July 31, 2023.
Rakesh Patel, Ph.D., Vice Chair for Research and Professor in the Division of Molecular & Cellular Pathology, will move into the role of Division Director, effective July 1, 2023. The Department will name an interim Vice Chair for Research to take over that role from Patel by the fall, 2023.
by Hannah Buckelew
Caroline Stanek, M.D., a PGY-2 in the UAB Department of Pathology, has recently been named a Society of '67 Kinney Scholar by the Association of Pathology Chairs (APC). This award is for pathology residents and medical students who demonstrate the potential for leadership in academic pathology. Stanek is 1 of 16 in the cohort of residents selected from across the United States.
The 2023 Tri-State Pathology Conference took place Saturday and Sunday, April 29-30, for the first time in four years, at the Lodge at Gulf State Park, bringing together the Alabama Association of Pathologists, the Louisiana Association of Pathologists, and the Mississippi Association of Pathologists for a stellar lineup of presentations. The event was co-sponsored by UAB Pathology and featured lectures from our faculty throughout the day, on a variety of topics representing their many areas of expertise.
Andrea Kahn, M.D., President of the Alabama Association of Pathologists, and Professor, Anatomic Pathology at UAB pathology, delivered the conference's opening and closing remarks and acted as emcee for the event. 
by Hannah Buckelew
Camilla Bell, M.Sc., Ph.D., an assistant professor in the UAB Department of Pathology’s Division of Molecular and Cellular Pathology, has been awarded a grant by Vertex Pharmaceuticals as part of the Research Innovation Award (RIA) for her proposal, “Impact of pathogenic immunity in CF-related diabetes.” Only two of these awards are given annually. This three-year $750,000 award will focus on the pathological immune response in cystic fibrosis related diabetes (CFRD).
Page 39 of 120